[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338599-105":59,"doc-detail-338599-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","androgen-receptor-and-osteoglycin-gene-expression-predicting-prognosis-of-metastatic-prostate-cancer","Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer","","Study identifies gene-expression predictive factors linked to oncological outcomes in metastatic hormone-sensitive prostate cancer. A nomogram for predicting prostate cancer-specific survival (CSS) was built from biopsy samples from 103 patients and externally validated in a separate cohort of 50 patients using a concordance index. Receiver operating characteristic–based cutoffs showed longer CSS in high osteoglycin and androgen receptor expression groups. The final model integrates clinical markers (hemoglobin, serum albumin, lactate dehydrogenase, and J-CAPRA score) with androgen receptor and osteoglycin expression, achieving concordance indices of 0.664 (internal) and 0.798 (external).",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/androgen-receptor-and-osteoglycin-gene-expression-predicting-prognosis-of-metastatic-prostate-cancer/338599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/androgen-receptor-and-osteoglycin-gene-expression-predicting-prognosis-of-metastatic-prostate-cancer/338599.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the primary goal of the study?","Question",{"text":113,"@type":114},"To identify predictive factors associated with oncological outcomes in metastatic hormone-sensitive prostate cancer and build a nomogram to estimate prostate cancer-specific survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the nomogram validated?",{"text":118,"@type":114},"It was internally tested using a cohort of 103 patients and externally validated in another cohort of 50 patients using concordance indices.",{"name":120,"@type":111,"acceptedAnswer":121},"Which gene expression levels were associated with better CSS?",{"text":122,"@type":114},"Higher osteoglycin and androgen receptor expression levels were associated with longer prostate cancer-specific survival compared with lower expression groups.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338599,1790168090,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAndrogen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer  \nTomohiro Kameda1, Toru Sugihara1􀀍, Daisuke Obinata2, Masashi Oshima3, Yuta Yamada4, Naoki Kimura4, Kenichi Takayama5, Satoshi Inoue5, Satoru Takahashi2 & Tetsuya Fujimura1  \nThis study aimed to identify the predictive factors associated with the oncological outcomes of metastatic hormone-sensitive prostate cancer-related genes. A nomogram for predicting prostate cancer-specific survival (CSS) was constructed based on biopsy samples obtained from 103 patients with metastatic hormone-sensitive prostate cancer. We analyzed the association between clinical data and mRNA expression levels. The nomogram was externally validated in another cohort  \n(n = 50) by using a concordance index. Based on the cutoff value, determined by a receiver operating characteristic analysis, longer CSS was observed in the high osteoglycin and androgen receptor expression level groups (> 1.133 and > 0.00; median CSS, 85.3 vs. 52.7 months, p = 0.045, and 69.1 vs. 32.1 months, p = 0.034, respectively), compared with that of the low expression level groups. Thenomogram predicting CSS included hemoglobin (≥ 13.7 g/dL or \u003C 13.7 g/dL), serum albumin (≥ 3.1 g/ dL or \u003C 3.1 g/dL), serum lactate dehydrogenase (≥ 222 IU/L or \u003C 222 IU/L), total Japan Cancer of the Prostate Risk Assessment score, androgen receptor expression level, and osteoglycin expression level. The concordance indices for the internal and external validations were 0.664 and 0.798, respectively. In this study, a nomogram that integrated the expression levels of androgen receptors and osteoglycin to predict CSS in metastatic hormone-sensitive prostate cancer was established.  \nProstate cancer is the second most frequent tumor type and the fifth leading cause of cancer-related mortality in men1. Although prostate cancer is often curable, recent epidemiological data have suggested an increasing frequency of metastatic prostate cancer2.  \nThe effectiveness of metastatic hormone-sensitive prostate cancer (mHSPC) treatment is highly variable and difficult to predict. Although clinical variables such as the Gleason score, tumor stage, and prostate-specific antigen (PSA) concentration have been used in various combinations to predict disease outcomes3,4, they do not accurately predict the clinical outcomes of individual patients. Therefore, improved biomarkers are required to determine patients that could benefit from more aggressive treatments and those that could be spared from unnecessary and potentially harmful interventions.  \nSeveral groups have attempted to develop tumor-derived RNA expression markers to enhance the predictive power of clinical variables5–7. However, no model has been established to predict the cancer-specific survival (CSS) of mHSPC (TableS1). We successfully extracted high-quality RNA using the laser-captured microdissection (LCM) method and formalin-fixed and paraffin-fixed prostate needle biopsy specimens from two independent cohorts of 10 types of androgen/estrogen signals and stem cell marker genes8. However, LCM is complicated; therefore, its application in clinical practice is difficult.  \nThe present study aimed to establish a simple and quantitative molecular diagnostic model using prostate biopsy specimens by simultaneously measuring epithelial and stromal markers. Here, we report on RNA extracted from prostate needle biopsy specimens of patients with mHSPC, using the Pure Link FFPE Total RNA Isolation Kit (Thermo Fisher Scientific, Waltham, MA, USA) and examine the correlation between genes and prognosis.  \n1Department of Urology, Jichi Medical University, 3311-1 Yakushiji Shimotsuke, Tochigi 329-0498, Japan.  \n2Department of Urology, Nihon University School of Medicine, Tokyo, Japan. 3Department of Urology, Sano Kosei General Hospital, Sano, Tochigi, Japan. 4Department of Urology, Graduate","cbCaid4MvvzUPYHV","https://ap.wps.com/l/cbCaid4MvvzUPYHV","pdf",1833469,"English","# Materials and methods\n## Tissue selections and patient characteristics","[{\"question\":\"What is the primary goal of the study?\",\"answer\":\"To identify predictive factors associated with oncological outcomes in metastatic hormone-sensitive prostate cancer and build a nomogram to estimate prostate cancer-specific survival.\"},{\"question\":\"How was the nomogram validated?\",\"answer\":\"It was internally tested using a cohort of 103 patients and externally validated in another cohort of 50 patients using concordance indices.\"},{\"question\":\"Which gene expression levels were associated with better CSS?\",\"answer\":\"Higher osteoglycin and androgen receptor expression levels were associated with longer prostate cancer-specific survival compared with lower expression groups.\"}]","Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer | PDF",1790024409,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebc495431ecb3843f89af77ab5e74b40.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8878a68be845e82dd42eaa5fb44de098.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e888b1e15a6c025bc088d16d497e8710.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea56d94957889cce4fcc53d384ffa51d.webp",980,1287]